DrugPatentWatch Database Preview
Prinston Inc Company Profile
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the competitive landscape for PRINSTON INC, and what generic and branded alternatives to PRINSTON INC drugs are available?
PRINSTON INC has fifty-eight approved drugs.
There are two tentative approvals on PRINSTON INC drugs.
Summary for Prinston Inc
| US Patents: | 0 |
| Tradenames: | 49 |
| Ingredients: | 49 |
| NDAs: | 58 |
Drugs and US Patents for Prinston Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prinston Inc | RISPERIDONE | risperidone | TABLET;ORAL | 077493-006 | Nov 29, 2011 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Prinston Inc | RISPERIDONE | risperidone | TABLET;ORAL | 077493-004 | Nov 29, 2011 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Prinston Inc | FUROSEMIDE | furosemide | TABLET;ORAL | 076796-001 | Mar 26, 2004 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Prinston Inc | IRBESARTAN AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; irbesartan | TABLET;ORAL | 203072-001 | May 9, 2014 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Prinston Inc | VALSARTAN AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; valsartan | TABLET;ORAL | 206083-004 | Feb 8, 2016 | AB | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
